Golden Lee Scott
PTC Therapeutics, Inc. · EVP & CHIEF MEDICAL OFFICER
Golden Lee Scott is listed in filings as EVP & CHIEF MEDICAL OFFICER at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 6, 2026, including sale activity. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT) and Cadrenal Therapeutics, Inc. Common Stock (CVKD). The current snapshot covers public activity from Dec 3, 2025 to Apr 6, 2026. Reported amounts are shown as $3.6M to $103.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $50k642 shares | SellJan 7, 2026 | $77.48 | $78.52 | |
| $103k1.3k shares | SellJan 6, 2026 | $76.95 | $78.52 | |
| $66k866 shares | SellJan 8, 2026 | $76.45 | $78.52 | |
| $172k2.5k shares | SellFeb 18, 2026 | $69.36 | $78.52 | |
| $634k10k shares | SellMar 5, 2026 | $63.38 | $78.52 |